Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: Therapeutic implications

Heart

Volumn 83, Issue 1, 2000, Pages 69-75

  Sasaki, Y ^a   Suehiro, S ^a   Becker, A E ^b   Kinoshita, H ^a   Ueda, M ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Platelet derived growth factor; Platelet receptor inhibitors; Smooth muscle cell proliferation; Vein graft stenosis

Indexed keywords

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; RESTENOSIS; VEIN GRAFT;

EID: 0034124263     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.1.69     Document Type: Article

References (25)

1. 1 Kalan JM, Roberts WC. Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-milimeter segments of veins. Am Heart J 1990;119:1164-84.
2. 2 van der Wal AC, Becker AE, Elbers JR, et al. An immunocytochemical analysis of rapidly progressive atherosclerosis in human vein grafts. Eur J Cardiothorac Surg 1992;6:469-73.
3. 3 Vlodaver Z, Edwards JE. Pathologic changes in aortic-coronary arterial saphenous vein grafts. Circulation 1971; 44:719-28.
4. 4 Unni KK, Kottke BA, Titus JL, et al. Pathologic changes in aortocoronary saphenous vein grafts. Am J Cardiol 1974;34:526-32.
5. 5 Amano J, Suzuki A, Sunamori M, et al. Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months. Am J Cardiol 1991;67:1234-6.
6. 6 Kockx MM, Cambier BA, Bortier HE, et al. The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts. Virchaws Arch [A] 1992;420:155-62.
7. 7 Austen WG. A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation 1975;51(suppl 4):5-40.
8. 8 Gown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986;125: 191-207.
9. 9 Gown AM, Vogel AM, Gordon D, et al. A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol 1985;100:807-13.
10. 10 van der Loos CM, Becker AE, van der Oord JJ. Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J 1993;25:1-13.
11. 11 Brody WR, Angell WW, Kosek JC. Histologic fate of the venous coronary artery bypass in dogs. Am J Pathol 1972;66:111-30.
12. 12 Hoch JR, Stark VK, Hullett DA, et al. Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. Surgery 1994;116:463-71.
13. 13 Libby P, Schwartz D, Brogi E, et al. A cascade model for restenosis, a special case of atherosclerosis progression. Circulation 1992;86(suppl):III-47-53.
14. 14 Ross R. The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature 1993;362:801-9.
15. 15 Ferns GAA, Raines EW, Sprugel KH, et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-32.
16. 16 Jawien A, Bowen-Pope DF, Lindner V, et al. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992;89:507-11.
17. 17 Ueda M, Becker AE, Kasayuki N, et al. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal angioplasty. Am J Pathol 1996;149:831-43.
18. 18 Tanizawa S, Ueda M, van der Loos CM, et al. Expression of platelet derived growth factor B chain and β receptor in human coronary arteries after percutaneous transluminal angioplasty: an immunohistochemical study. Heart 1996; 75:549-56.
19. 19 Gabbiani G, Kocher O, Bloom WS, et al. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atherosclerotic plaque, and cultured rat aortic media. J Clin Invest 1984;73:148-52.
20. 20 Kocher O, Gabbiani F, Gabbiani G, et al. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Lab Invest 1991;65:459-70.
21. 21 Ueda M, Becker AE, Tsukada T, et al. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation 1991;83:1327-32.
22. 22 Ueda M, Becker AE, Naruko T, et al. Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Coron Artery Dis 1995;6:71-81.
23. 23 Bai H, Masuda J, Sawa Y, et al. Neointimal formation after vascular stent implantation, spatial and chronological distribution of smooth muscle cell proliferation and phenotypic modulation. Arterioscler Thromb 1994:14:1846-53.
24. 24 Takagi M, Ueda M, Becker AE, et al. The Watanabe heritable hyperlipidemic rabbit is a suitable experimental model to study differences in tissue response between intimal and medial injury after balloon angioplasty. Arterioscler Thromb Vasc Biol 1997;17:3611-19.
25. 25 OBrien ER, Alperts CE, Stewart DK, et al. Proliferation in primary and restenotic coronary atherectomy tissue. Implication for antiproliferative therapy. Circ Res 1993;73:223-31.